Company Overview - Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cell therapies for AL Amyloidosis and other serious diseases [8] - The lead candidate is NXC-201, a sterically-optimized BCMA-targeted CAR-T cell therapy [5][8] - NXC-201 has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA and Orphan Drug Designation (ODD) from both the FDA and EMA [5][9] Clinical Trials - The ongoing NEXICART-2 trial (NCT06097832) is a single-arm multi-site Phase 1/2 clinical trial evaluating NXC-201 in relapsed/refractory AL Amyloidosis [4] - The trial aims to enroll 40 patients with preserved heart function who have not previously received BCMA-targeted therapy [4] - The primary endpoint for Phase 1 is safety, while for Phase 2 it is efficacy [4] Upcoming Presentation - Interim readout data from the NEXICART-2 trial will be presented at the 2025 American Society of Clinical Oncology Annual Meeting (ASCO 2025) in Chicago [2] - The presentation is scheduled for June 3, 2025, and will be led by Dr. Heather Landau from Memorial Sloan-Kettering Cancer Center [2][3] Market Insights - The U.S. prevalence of relapsed/refractory AL Amyloidosis is estimated to grow at 12% per year, reaching approximately 33,277 patients in 2024 [7] - The amyloidosis market was valued at $3.6 billion in 2017 and is projected to reach $6 billion by 2025 [7]

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (NASDAQ:BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that updated data from the company's ongoing Phase 1/1b clinical trial of ficerafusp alfa in 1L (first line) recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) will be highlighted in an oral presentation at the 2025 American Society of Clinical Oncology (AS ...

Roomba® Max 705 Vac Provides 180x more suction power and 75 days of hands-free cleaningBEDFORD, Mass., April 23, 2025 /PRNewswire/ -- iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced the availability of the Roomba® Max 705 Vac Robot + AutoEmpty™ Dock in North America and select European markets. Engineered to keep busy, pet-loving homes spotless, the new Roomba® Max 705 Vac offers our highest level of vacuuming and cleaning with 180x more power-lifting suction1, Dual-Rubber Brushes, ...

As an official partner of Churchill Downs Inc., FanDuel will once again deliver unmatched access during Derby Week with premier betting options, live FanDuel TV broadcasts, and exclusive events  Churchill Downs®, Kentucky Derby®, Kentucky Oaks® and the Twin Spires® are registered trademarks of Churchill Downs Incorporated NEW YORK, April 23, 2025 /PRNewswire/ -- FanDuel, North America's premier online gaming company, is off to the races for the 151st "Run for the Roses" with the #1 sportsbook app where fans ...

ALK (ALKB.DC / OMX: ALK B) today announced that its European regulatory filing for ITULAZAX® (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged five to 17 has been approved by the health authorities in 17 EU countries via a type II variation procedure. First market introductions are expected to follow in the coming months ahead of the 2025/2026 initiation season for new patients starting treatment on pollen allergy tablets. Executive Vice President of ...

Today, the Board of Directors of Havila Shipping ASA has approved the financial statements for 2024 for both the Group and the parent company.The numbers are in line with preliminary accounts released on 26 February 2025.Contacts:Chief Executive Officer Njål Sævik, +47 909 35 722Chief Financial Officer Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments HAVI2024 5967007LIEEXZXFJ8876-2024 ...

øbenhavn, den 23. april 2025 Ordinær generalforsamling PARKEN Sport & Entertainment A/S har afholdt ordinær generalforsamling den 23. april 2025 med følgende dagsorden: Udpegning af dirigent. Bestyrelsens beretning. Forelæggelse af den reviderede årsrapport til godkendelse. Beslutning om anvendelse af overskud i henhold til den godkendte årsrapport. Præsentation af og vejledende afstemning om vederlagsrapport for 2024.Forslag fra bestyrelse og aktionærer. Valg af medlemmer til bestyrelsen. Valg af revisor. ...

SHEFFIELD, United Kingdom, April 23, 2025 (GLOBE NEWSWIRE) -- Caro Holdings announces the release of its new AI Chat Agent platform - an intelligent, always-on assistant team built to help businesses save time, cut costs, and deliver top-tier customer service without hiring additional staff. Caro’s smart agents handle tasks that typically consume team resources, including: Instant Support - answering FAQs like return policies or product detailsAppointment Scheduling - enabling bookings through chatOrder Tra ...

DOWNINGTOWN, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Chester County townhome community, Stonemill Village, is now open for sale. The Toll Brothers Sales Center and model home are open for tours at 5 Grayson Lane in Downingtown, Pennsylvania. Located in the prestigious Downingtown Area School District, Stonemill Village will feature 89 two-story townhomes in a quiet neighborhood close to every convenience ...

Calls for Accountability and Shareholder-Centered ReformBUFFALO, N.Y., April 23, 2025 /PRNewswire/ -- Beaver Hollow Wellness, LLC ("BHW"), the largest active shareholder of Servotronics, Inc. (NASDAQ: SVT), today issued the following statement in response to the Company's amended proxy statement filed April 22, 2025:"Servotronics' latest filing is a clear sign of a board under pressure and out of touch," said Paul L. Snyder III, Chairman of BHW. "The escalation in rhetoric, along with newly inserted languag ...